COSCIENS Biopharma Inc. Adjustments For Fair Value Gains Losses
COSCIENS Biopharma Inc. (CSCIF) reported Adjustments For Fair Value Gains Losses of -$1.15 million for the 12-month period ending 2020-12-31, per its 20-F/A filed 2024-02-15.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForFairValueGainsLosses · last filed 2024-02-15
| Period end | Adjustments For Fair Value Gains Losses 12 month |
|---|---|
| 2020-12-31 | -$1.15M 20-F/A · filed 2024-02-15 |